Drugs in development for toxoplasmosis: advances, challenges, and current status

PH Alday, JS Doggett - Drug design, development and therapy, 2017 - Taylor & Francis
Toxoplasma gondii causes fatal and debilitating brain and eye diseases. Medicines that are
currently used to treat toxoplasmosis commonly have toxic side effects and require …

Diaryl ether: a privileged scaffold for drug and agrochemical discovery

T Chen, H Xiong, JF Yang, XL Zhu… - Journal of Agricultural …, 2020 - ACS Publications
Diaryl ether (DE) is a functional scaffold existing widely both in natural products (NPs) and
synthetic organic compounds. Statistically, DE is the second most popular and enduring …

Transition metal-catalyzed coupling of heterocyclic alkenes via C–H functionalization: recent trends and applications

SV Kumar, S Banerjee, T Punniyamurthy - Organic Chemistry Frontiers, 2020 - pubs.rsc.org
Heterocyclic alkenes represent an important class of reactive feedstock and valuable
synthons for the synthesis of biologically important heterocyclic scaffolds. Although …

Antiplasmodial and antimalarial activities of quinolone derivatives: An overview

YL Fan, XW Cheng, JB Wu, M Liu, FZ Zhang… - European Journal of …, 2018 - Elsevier
Malaria remains one of the most deadly infectious diseases globally. Considering the
growing spread of resistance, development of new and effective antimalarials remains an …

Treatment of human babesiosis: then and now

I Renard, C Ben Mamoun - Pathogens, 2021 - mdpi.com
Babesiosis is an emerging tick-borne disease caused by apicomplexan parasites of the
genus Babesia. With its increasing incidence worldwide and the risk of human-to-human …

Gold‐catalyzed [4+ 2] annulation/cyclization cascades of benzisoxazoles with propiolate derivatives to access highly oxygenated tetrahydroquinolines

RL Sahani, RS Liu - Angewandte Chemie, 2017 - Wiley Online Library
This work describes gold‐catalyzed annulations of electron‐deficient alkynes with
benzisoxazoles to yield quinoline oxides chemoselectively. Chemical functionalizations of …

Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1

MJ Capper, PM O'Neill, N Fisher… - Proceedings of the …, 2015 - National Acad Sciences
Cytochrome bc 1 is a proven drug target in the prevention and treatment of malaria. The rise
in drug-resistant strains of Plasmodium falciparum, the organism responsible for malaria …

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

JF Armstrong, B Campo, SPH Alexander… - British Journal of …, 2023 - Wiley Online Library
Antimalarial drug discovery has until recently been driven by high‐throughput phenotypic
cellular screening, allowing millions of compounds to be assayed and delivering clinical …

Radical cure of experimental babesiosis in immunodeficient mice using a combination of an endochin-like quinolone and atovaquone

LA Lawres, A Garg, V Kumar, I Bruzual… - Journal of Experimental …, 2016 - rupress.org
Human babesiosis is a tick-borne multisystem disease caused by Babesia species of the
apicomplexan phylum. Most clinical cases and fatalities of babesiosis are caused by …

MalariaFlow: A comprehensive deep learning platform for multistage phenotypic antimalarial drug discovery

M Lin, J Cai, Y Wei, X Peng, Q Luo, B Li, Y Chen… - European Journal of …, 2024 - Elsevier
Malaria remains a significant global health challenge due to the growing drug resistance of
Plasmodium parasites and the failure to block transmission within human host. While …